Venture-Backed Startups
146,404 companies with verified investor relationships.
Acorn Energy operates OmniMetrix, a subsidiary that builds wireless remote monitoring and control systems for backup power generators, cell towers, data centers, utilities, and other critical infrastructure. It provides monitoring hardware plus recurring subscription services to generator dealers, telecom operators, and infrastructure asset managers.
0 investors
Acorn Finance operates a lending-network platform that connects contractors and their customers with multiple third-party lenders, letting homeowners compare and secure home improvement financing while contractors get paid upfront. It serves contractors in home improvement, remodeling, HVAC, roofing, landscaping, and solar, offering loans up to $100,000 at no cost to the contractor.
6 investors
Acorn Holdings Africa is a real estate development and project management company that has delivered over 50 commercial, residential, and hospitality projects across East Africa since 2001. The firm specializes in office buildings, mixed-use developments, retail spaces, and hotel properties primarily serving institutional clients and private developers in Kenya and Uganda.
2 investors
0 investors
0 investors
Acorn Genetics is developing technology to detect genetic and epigenetic markers rapidly and on-site, without sending samples to central labs. Its applications span disease marker detection and genomic monitoring for crop protection, ecosystems, and food security.
1 investor
Acorns provides automated investment services that allow users to invest in diversified portfolios of exchange-traded funds (ETFs) composed of stocks and bonds, with options including Bitcoin-linked ETFs. The platform serves individual investors seeking to build wealth through portfolio management tailored to their age, time horizon, and risk tolerance.
19 investors
Acoru is a fraud prevention and cybersecurity company founded by former Buguroo/Revelock leaders, focused on detecting and preventing online fraud at scale. It serves organizations protecting large user and device bases against dynamic fraud threats.
3 investors
Acosta connects brands with consumers through distribution and agency services, facilitating market relationships since 1927. The company specializes in brand representation and client activation across modern retail channels.
2 investors
AcouBatt provides acoustic monitoring and AI-based detection for battery energy storage systems, identifying abnormal cell behavior and safety risks in real time. The system helps operators prevent thermal runaway, unplanned downtime, and degradation across battery racks through early warning signals.
1 investor
Acousia Therapeutics develops small-molecule drug candidates with a dual mode of action for treating acute and chronic sensorineural hearing loss (SNHL), targeting outer hair cells in the inner ear to preserve and enhance natural hearing. The biotech company focuses on drug therapies as a first-line or complementary option to hearing aids and cochlear implants.
2 investors
Acouspin develops ultrasound-enhanced, AI-driven nanofiber manufacturing technology that addresses scalability and consistency challenges in electrospinning for industrial applications. The company serves manufacturers seeking advanced materials for filtration, tissue engineering, composites, and other sectors.
1 investor
A construction company with over 80 years of industry experience that operates across multiple regional offices in Florida, Mid-Atlantic, and other U.S. regions.
1 investor
Acoustic is a marketing technology company that provides a customer engagement platform for lifecycle marketers to understand consumer intent and drive engagement through real-time behavioral data and AI-powered analytics. The platform helps teams move beyond traditional campaign cycles toward a modern, intent-driven marketing approach.
2 investors
Show Tire develops tire innovation technology, particularly DBCR technology, to improve vehicle comfort and safety for customers and support their driving experience.
1 investor
0 investors
Acoustica.bio develops acoustophoretic technology and microgel suspension formulations that concentrate biologic drugs (such as monoclonal antibodies) to ultra-high concentrations exceeding 500 mg/mL for small-volume subcutaneous injection. It serves drug developers, aiming to convert hospital-based intravenous therapies into patient-friendly at-home injections in the biotech/drug delivery space.
3 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors







